Large and low-PEG lipid nanoparticles enable efficient dendritic cell targeting for potent mRNA Cancer vaccines

Key Points

• Effective dendritic cell targeting enhances immune response against cancer.
• Lipid nanoparticles facilitate the delivery of mRNA to dendritic cells for better activation.
• Using low-PEG lipid nanoparticles improves the stability and uptake of mRNA.
• This approach may enable more effective cancer vaccines, warranting further exploration.